비교리스트

 카트 문의
시장보고서
상품코드
1538445

부신피질 호르몬 API 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

Adrenocortical Hormone API Market Report: Trends, Forecast and Competitive Analysis to 2030
발행일: | 리서치사: Lucintel | 페이지 정보: 영문 150 Pages | 배송안내 : 3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

부신피질 호르몬 API 동향과 예측

세계의 부신피질 호르몬 API 시장은 2024-2030년에 CAGR 5.9%로 성장할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 호르몬 대체요법에 대한 수요 증가와 부신 기능 부전 질환의 유병률 증가입니다. 세계 부신피질 호르몬 API 시장의 미래는 주사제, 경구제, 외용제, 흡입제 시장에서의 기회로 인해 유망합니다.

부신피질호르몬 API : 부문별

이 보고서에는 전 세계 부신피질 호르몬 API의 유형별, 용도별, 지역별 예측이 포함되어 있습니다.

부신피질호르몬 API 시장 인사이트

Lucintel의 예측에 따르면 프레드니손 계열이 가장 높은 성장을 보일 것으로 예상됩니다.

주사제가 이 시장에서 가장 높은 성장세를 보일 것으로 예상됩니다.

북미가 가장 높은 성장이 예상됩니다.

자주 묻는 질문

Q1. 시장의 성장 예측은 :

A1. 세계 부신피질 호르몬 API 시장은 2024-2030년 연평균 5.9%의 성장률을 보일 것으로 예상됩니다.

Q2. 시장 성장에 영향을 미치는 주요 촉진요인은 :

A2.이 시장의 주요 촉진요인은 호르몬 대체요법에 대한 수요 증가와 부신 기능 부전 질환의 유병률 증가입니다.

Q3. 시장의 주요 부문은 :

A3. 부신피질 호르몬 API 시장의 미래는 주사제, 경구제, 외용제, 흡입제 시장에서의 기회로 인해 유망합니다.

Q4. 시장의 주요 기업은 :

A4. 주요 부신피질 호르몬 API 기업은 다음과 같습니다. :

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab

Q5. 향후 최대가 되는 시장 부문은 :

A5.Lucintel은 프레드니손 시리즈가 가장 높은 성장을 이룰 것으로 예상했습니다.

Q6. 시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은 :

A6. 북미가 가장 높은 성장세를 보일 것으로 예상됩니다.

Q7. 리포트의 커스터마이즈는 가능한가? :

A7. 네. Lucintel은 추가 비용없이 10%의 커스터마이즈를 제공합니다.

목차

제1장 개요

제2장 세계의 부신피질 호르몬 API 시장 : 시장 역학

  • 서론, 배경, 분류
  • 공급망
  • 업계의 촉진요인과 과제

제3장 2018-2030년 시장 동향과 예측 분석

  • 거시경제 동향(2018-2023년)과 예측(2024-2030년)
  • 세계의 부신피질 호르몬 API 시장 동향(2018-2023년)과 예측(2024-2030년)
  • 세계의 부신피질 호르몬 API 시장 : 유형별
    • Prednisone Series
    • Dexamethasone Series
    • Betamethasone Series
    • Hydrocortisone Series
    • 기타
  • 세계의 부신피질 호르몬 API 시장 : 용도별
    • 주사제
    • 경구제
    • 외용제
    • 흡입제

제4장 2018-2030년 지역별 시장 동향과 예측 분석

  • 지역별 부신피질 호르몬 API 세계 시장
  • 북미의 부신피질 호르몬 API 시장
  • 유럽의 부신피질 호르몬 API 시장
  • 아시아태평양의 부신피질 호르몬 API 시장
  • 기타 지역의 부신피질 호르몬 API 시장

제5장 경쟁 분석

  • 제품 포트폴리오 분석
  • 업무 통합
  • Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

  • 성장 기회 분석
  • 세계의 부신피질 호르몬 API 시장의 새로운 동향
  • 전략 분석
    • 신제품 개발
    • 세계의 부신피질 호르몬 API 시장의 능력 확대
    • 세계의 부신피질 호르몬 API 시장의 합병, 인수, 합병사업
    • 인증과 라이선싱

제7장 주요 기업의 기업 개요

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab
KSA 24.09.27

Adrenocortical Hormone API Trends and Forecast

The future of the global adrenocortical hormone API market looks promising with opportunities in the injectable drug, oral drug, for external use drug, and inhalation drug markets. The global adrenocortical hormone API market is expected to grow with a CAGR of 5.9% from 2024 to 2030. The major drivers for this market are growing demand for hormonal replacement therapies and rising prevalence of adrenal insufficiency disorders.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Adrenocortical Hormone API by Segment

The study includes a forecast for the global adrenocortical hormone API by type, application, and region.

Adrenocortical Hormone API Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Prednisone Series
  • Dexamethasone Series
  • Betamethasone Series
  • Hydrocortisone Series
  • Others

Adrenocortical Hormone API Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Injectable Drug
  • Oral Drug
  • For External Use Drug
  • Inhalation Drug

Adrenocortical Hormone API Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Adrenocortical Hormone API Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies adrenocortical hormone API companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adrenocortical hormone API companies profiled in this report include-

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab

Adrenocortical Hormone API Market Insights

Lucintel forecasts that prednisone series is expected to witness the highest growth.

Within this market, injectable drug is expected to witness the highest growth.

North America is expected to witness the highest growth.

Features of the Global Adrenocortical Hormone API Market

Market Size Estimates: Adrenocortical hormone API market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Adrenocortical hormone API market size by type, application, and region in terms of value ($B).

Regional Analysis: Adrenocortical hormone API market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the adrenocortical hormone API market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the adrenocortical hormone API market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for adrenocortical hormone API market?

Answer: The global adrenocortical hormone API market is expected to grow with a CAGR of 5.9% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the adrenocortical hormone API market?

Answer: The major drivers for this market are growing demand for hormonal replacement therapies and rising prevalence of adrenal insufficiency disorders.

Q3. What are the major segments for adrenocortical hormone API market?

Answer: The future of the adrenocortical hormone API market looks promising with opportunities in the injectable drug, oral drug, for external use drug, and inhalation drug markets.

Q4. Who are the key adrenocortical hormone API market companies?

Answer: Some of the key adrenocortical hormone API companies are as follows:

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab

Q5. Which adrenocortical hormone API market segment will be the largest in future?

Answer: Lucintel forecasts that prednisone series is expected to witness the highest growth.

Q6. In adrenocortical hormone API market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the adrenocortical hormone API market by type (prednisone series, dexamethasone series, betamethasone series, hydrocortisone series, and others), application (injectable drug, oral drug, for external use drug, and inhalation drug), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Adrenocortical Hormone API Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Adrenocortical Hormone API Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Adrenocortical Hormone API Market by Type
    • 3.3.1: Prednisone Series
    • 3.3.2: Dexamethasone Series
    • 3.3.3: Betamethasone Series
    • 3.3.4: Hydrocortisone Series
    • 3.3.5: Others
  • 3.4: Global Adrenocortical Hormone API Market by Application
    • 3.4.1: Injectable Drug
    • 3.4.2: Oral Drug
    • 3.4.3: For External Use Drug
    • 3.4.4: Inhalation Drug

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Adrenocortical Hormone API Market by Region
  • 4.2: North American Adrenocortical Hormone API Market
    • 4.2.1: North American Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.2.2: North American Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
  • 4.3: European Adrenocortical Hormone API Market
    • 4.3.1: European Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.3.2: European Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
  • 4.4: APAC Adrenocortical Hormone API Market
    • 4.4.1: APAC Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.4.2: APAC Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
  • 4.5: ROW Adrenocortical Hormone API Market
    • 4.5.1: ROW Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.5.2: ROW Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Adrenocortical Hormone API Market by Type
    • 6.1.2: Growth Opportunities for the Global Adrenocortical Hormone API Market by Application
    • 6.1.3: Growth Opportunities for the Global Adrenocortical Hormone API Market by Region
  • 6.2: Emerging Trends in the Global Adrenocortical Hormone API Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Adrenocortical Hormone API Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Adrenocortical Hormone API Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer CentreOne
  • 7.2: EuroAPI
  • 7.3: GlaxoSmithKline
  • 7.4: Teva Pharmaceutical Industries
  • 7.5: Hovione
  • 7.6: Axplora
  • 7.7: Steroid Spa
  • 7.8: Avik Pharmaceutical
  • 7.9: Anuh Pharma
  • 7.10: Symbiotec Pharmalab
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제